Acute Phase Reactants

Products Related to Acute Phase Reactants(15)

GC18219 6-hydroxy Warfarin
CAS: 17834-02-5
Purity: >98.00%
6-hydroxy Warfarin is a metabolite of (+)-warfarin , which is a weaker vitamin K antagonist than (-)-warfarin .
GC40529 7-hydroxy Warfarin
CAS: 17834-03-6
Purity: >98%
7-hydroxy Warfarin is a metabolite of (-)-warfarin, which is a more potent vitamin K antagonist than (+)-warfarin.
GC48060 Rosuvastatin-d6 (sodium salt)
CAS: 2070009-41-3
Purity: >98.50%
An internal standard for the quantification of rosuvastatin
GC49107 Rosuvastatin lactone
CAS: 503610-43-3
Purity: >98.00%
The lactone form of rosuvastatin
GC49118 10-hydroxy Warfarin
CAS: 83219-99-2
Purity: >95.00%
A metabolite of (R)-warfarin
GC49131 Dehydro Warfarin
CAS: 67588-18-5
Purity: >95.00%
A metabolite of (±)-warfarin
GC49266 Compstatin (trifluoroacetate salt)
Purity: >98.00%
A peptide inhibitor of complement activation
GC49784 AZD 2716
CAS: 1845753-81-2
Purity: >98.00%
An sPLA 2 inhibitor
GC52084 YSK05
CAS: 1318793-78-0
Purity: >90.00%
YSK05 is a pH-sensitive cationic lipid. YSK05 improves the intracellular trafficking of non-viral vectors. YSK05-MEND shows significantly good gene silencing activity and hemolytic activity. YSK05 overcomes the suppression of endosomal escape by PEGylation. YSK05 effectively enhances siRNA delivery both in vitro and in vivo.
GC52193 Eptifibatide
CAS: 188627-80-7
Purity: >98.00%
Eptifibatide is a cyclic heptapeptide, acts as a competitive antagonist for the activated platelet glycoprotein IIb/IIIa receptor, with anti-platelet activity.
GC52359 ATX-100
CAS: 2230647-37-5
Purity: >98.00%
An ionizable cationic lipid
GC72527 S-(-)-Warfarin
CAS: 5543-57-7
GC90490 PMX-53 (trifluoroacetate salt)
CAS: 514814-99-4
Purity: >95.00%
A C5a receptor antagonist
GC90684 Lipid 2,2(8,8) 4C CH3
CAS: 2230647-30-8
Purity: >95.00%
An ionizable cationic lipid
GC90993 CL4F8-6
CAS: 2766493-12-1
Purity: >98.00%
An ionizable cationic lipid

Category Product List
Catalog No.	Product Name	CAS No.	Purity
GC18219	6-hydroxy Warfarin	17834-02-5	>98.00%
GC18219	6-hydroxy Warfarin is a metabolite of (+)-warfarin , which is a weaker vitamin K antagonist than (-)-warfarin .
GC40529	7-hydroxy Warfarin	17834-03-6	>98%
GC40529	7-hydroxy Warfarin is a metabolite of (-)-warfarin, which is a more potent vitamin K antagonist than (+)-warfarin.
GC48060	Rosuvastatin-d6 (sodium salt)	2070009-41-3	>98.50%
GC48060	An internal standard for the quantification of rosuvastatin
GC49107	Rosuvastatin lactone	503610-43-3	>98.00%
GC49107	The lactone form of rosuvastatin
GC49118	10-hydroxy Warfarin	83219-99-2	>95.00%
GC49118	A metabolite of (R)-warfarin
GC49131	Dehydro Warfarin	67588-18-5	>95.00%
GC49131	A metabolite of (±)-warfarin
GC49266	Compstatin (trifluoroacetate salt)	-	>98.00%
GC49266	A peptide inhibitor of complement activation
GC49784	AZD 2716	1845753-81-2	>98.00%
GC49784	An sPLA 2 inhibitor
GC52084	YSK05	1318793-78-0	>90.00%
GC52084	YSK05 is a pH-sensitive cationic lipid. YSK05 improves the intracellular trafficking of non-viral vectors. YSK05-MEND shows significantly good gene silencing activity and hemolytic activity. YSK05 overcomes the suppression of endosomal escape by PEGylation. YSK05 effectively enhances siRNA delivery both in vitro and in vivo.
GC52193	Eptifibatide	188627-80-7	>98.00%
GC52193	Eptifibatide is a cyclic heptapeptide, acts as a competitive antagonist for the activated platelet glycoprotein IIb/IIIa receptor, with anti-platelet activity.
GC52359	ATX-100	2230647-37-5	>98.00%
GC52359	An ionizable cationic lipid
GC72527	S-(-)-Warfarin	5543-57-7	-
GC90490	PMX-53 (trifluoroacetate salt)	514814-99-4	>95.00%
GC90490	A C5a receptor antagonist
GC90684	Lipid 2,2(8,8) 4C CH3	2230647-30-8	>95.00%
GC90684	An ionizable cationic lipid
GC90993	CL4F8-6	2766493-12-1	>98.00%
GC90993	An ionizable cationic lipid